[HTML][HTML] Oral lichen planus and its relationship with systemic diseases. A review of evidence
J Cassol-Spanemberg… - Journal of clinical and …, 2018 - ncbi.nlm.nih.gov
Oral lichen planus and its relationship with systemic diseases. A review of evidence - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
[HTML][HTML] Oral ulcers presentation in systemic diseases: an update
BACKGROUND: Diagnosis of oral ulceration is always challenging and has been the source
of difficulty because of the remarkable overlap in their clinical presentations. AIM: The …
of difficulty because of the remarkable overlap in their clinical presentations. AIM: The …
Therapeutic efficacy of fresh, autologous mesenchymal stem cells for severe refractory gingivostomatitis in cats
Mesenchymal stem cells (MSCs) are a promising therapy for immune-mediated and
inflammatory disorders, because of their potent immunomodulatory properties. In this study …
inflammatory disorders, because of their potent immunomodulatory properties. In this study …
Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory feline chronic gingivostomatitis
Mesenchymal stem cells (MSCs) have potent immunomodulatory functions and are a
promising therapy for immune-mediated inflammatory disorders. We previously …
promising therapy for immune-mediated inflammatory disorders. We previously …
Oral lichen planus clinical characteristics in Italian patients: a retrospective analysis
D Lauritano, M Arrica, A Lucchese, M Valente… - Head & face …, 2016 - Springer
Abstract Background Oral lichen Planus (OLP) is a chronic inflammatory disease involving
skin and mucous membranes. Its etiology is still uncertain whilst an autoimmune mechanism …
skin and mucous membranes. Its etiology is still uncertain whilst an autoimmune mechanism …
Emerging potential of phototherapy in management of symptomatic oral lichen planus: A systematic review of randomised controlled clinical trials
R Hanna, S Dalvi, G Tomov, C Hopper… - Journal of …, 2023 - Wiley Online Library
Phototherapy incorporating photobiomodulation therapy and antimicrobial photodynamic
therapy has been utilised as antioxidants in symptomatic oral lichen planus (OLP) …
therapy has been utilised as antioxidants in symptomatic oral lichen planus (OLP) …
[HTML][HTML] Oral lichen planus: a novel staging and algorithmic approach and all that is essential to know
E Shavit, H Klieb, NH Shear - F1000Research, 2020 - ncbi.nlm.nih.gov
Lichen planus (LP) is a chronic autoimmune disease. Oral lesions may occur in isolation or
in combination with other affected muco-cutaneous sites. Oral LP (OLP) may present as one …
in combination with other affected muco-cutaneous sites. Oral LP (OLP) may present as one …
Single-cell immune profiling reveals immune responses in oral lichen planus
Q Li, F Wang, Y Shi, L Zhong, S Duan… - Frontiers in …, 2023 - frontiersin.org
Introduction Oral lichen planus (OLP) is a common chronic inflammatory disorder of the oral
mucosa with an unclear etiology. Several types of immune cells are involved in the …
mucosa with an unclear etiology. Several types of immune cells are involved in the …
[HTML][HTML] Implants in patients with oral manifestations of autoimmune or muco-cutaneous diseases–A systematic review
FP Strietzel, AM Schmidt-Westhausen… - … oral, Patologia oral y …, 2019 - ncbi.nlm.nih.gov
Background To give an overview on implant survival rates in patients with oral
manifestations of systemic autoimmune (oral Lichen planus (oLp), Pemphigus (Pe)), muco …
manifestations of systemic autoimmune (oral Lichen planus (oLp), Pemphigus (Pe)), muco …
The effects of photodynamic and low-level laser therapy for treatment of oral lichen planus—a systematic review and meta-analysis
Background Oral lichen planus (OLP) is a chronic immune-mediated disorder that inflicts
oral mucosa in 0.5–2% of the population. Surgery, photodynamic therapy, laser therapy and …
oral mucosa in 0.5–2% of the population. Surgery, photodynamic therapy, laser therapy and …